1. Home
  2. ELDN vs ZH Comparison

ELDN vs ZH Comparison

Compare ELDN & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.97

Market Cap

219.4M

Sector

Health Care

ML Signal

HOLD

Logo Zhihu Inc. (every two of each representing one ordinary share)

ZH

Zhihu Inc. (every two of each representing one ordinary share)

SELL

Current Price

$2.54

Market Cap

222.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
ELDN
ZH
Founded
2004
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
219.4M
222.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ELDN
ZH
Price
$1.97
$2.54
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
★ $9.00
$4.09
AVG Volume (30 Days)
★ 918.4K
253.2K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.06
P/E Ratio
★ N/A
$20.74
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$2.51
52 Week High
$4.49
$4.52

Technical Indicators

Market Signals
Indicator
ELDN
ZH
Relative Strength Index (RSI) 35.64 30.77
Support Level N/A N/A
Resistance Level $3.14 $3.42
Average True Range (ATR) 0.27 0.20
MACD -0.07 -0.02
Stochastic Oscillator 3.83 3.33

Price Performance

Historical Comparison
ELDN
ZH

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.

Share on Social Networks: